Martin Bauer

Where are you point-ing at

Gerd Kortuem, Z. Segall, Martin Bauer, 1999 .

In Vivo Imaging of Dopamine Metabolism and Dopamine Transporter Function in the Human Brain

Matthäus Willeit, Nicole Praschak-Rieder, Martin Bauer, 2016 .

Microdosing studies in humans: the role of positron emission tomography.

Oliver Langer, Martin Bauer, O. Langer, 2008, Drugs in R&D.

Assessment of Regional Differences in Tariquidar-Induced P-Glycoprotein Modulation at the Human Blood–Brain Barrier

Friederike Neumann, Wolfgang Löscher, Oliver Langer, 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

A Combined Accelerator Mass Spectrometry-Positron Emission Tomography Human Microdose Study with 14C- and 11C-Labelled Verapamil

Aiman Abrahim, Oliver Langer, Rudolf Karch, 2011, Clinical pharmacokinetics.

A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease

Rupert Lanzenberger, Gianluigi Forloni, Aiman Abrahim, 2006, Clinical pharmacology and therapeutics.

Microdosing Studies in Humans

Oliver Langer, Martin Bauer, O. Langer, 2008 .

Pharmacoresistance in Epilepsy : A Pilot PET Study with the P-Glycoprotein Substrate R-[ 11 C ] verapamil ∗ †

Alexander Hammers, Gert Luurtsema, Aiman Abrahim, 2007 .

A Pilot Study to Assess the Efficacy of Tariquidar to Inhibit P-glycoprotein at the Human Blood–Brain Barrier with (R)-11C-Verapamil and PET

Stephan Kopp, Peter Chiba, Wolfgang Löscher, 2009, Journal of Nuclear Medicine.

Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET

Friederike Neumann, Aiman Abrahim, Oliver Langer, 2009, European Journal of Clinical Pharmacology.